Search research articles
Contact Us
Filters
Showing results (821-830 of 834) with videos related to
Page
of 84
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 22, 2020
MILO/ENGOT-ov11: Binimetinib Versus Physician's Choice Chemotherapy in Recurrent or Persistent Low-Grade Serous Carcinomas of the Ovary, Fallopian Tube, or Primary Peritoneum
Bradley J Monk, Rachel N Grisham, Susana Banerjee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 23, 2025
Primary Analysis of EPIK-O/ENGOT-ov61: Alpelisib Plus Olaparib Versus Chemotherapy in Platinum-Resistant or Platinum-Refractory High-Grade Serous Ovarian Cancer Without <i>BRCA</i> Mutation
Panagiotis A Konstantinopoulos, Jae Weon Kim, Gilles Freyer, et al.
JCO Oncology Practice
|
May 30, 2020
InSight Care Pilot Program: Redefining Seeing a Patient
Bobby Daly, Gilad Kuperman, Alice Zervoudakis, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
June 24, 2025
Comprehensive Molecular, Pathological, and Clinical Characterization of Clear Cell Adenocarcinoma of the Urinary Tract
Rayan Rammal, Florestan J Koll, Ziyu Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 21, 2021
Secondary Cytoreduction and Carboplatin Hyperthermic Intraperitoneal Chemotherapy for Platinum-Sensitive Recurrent Ovarian Cancer: An MSK Team Ovary Phase II Study
Oliver Zivanovic, Dennis S Chi, Qin Zhou, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
February 5, 2021
Ovarian Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
Deborah K Armstrong, Ronald D Alvarez, Jamie N Bakkum-Gamez, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
October 16, 2024
NCCN Guidelines® Insights: Ovarian Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancer, Version 3.2024
Joyce Liu, Andrew Berchuck, Floor J Backes, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
September 8, 2022
NCCN Guidelines® Insights: Ovarian Cancer, Version 3.2022
Deborah K Armstrong, Ronald D Alvarez, Floor J Backes, et al.
JCO Precision Oncology
|
September 22, 2023
Germline Pathogenic Variants and Genetic Counseling by Ancestry in Patients With Epithelial Ovarian Cancer
Tiffany Y Sia, Anna Maio, Yelena M Kemel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 3, 2018
Clinical Utility of Prospective Molecular Characterization in Advanced Endometrial Cancer
Tara E Soumerai, Mark T A Donoghue, Chaitanya Bandlamudi, et al.
Page
of 84
Search research articles
Search
Showing results (821-830 of 834) with videos related to
Sort By:
Page
of 84
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 22, 2020
MILO/ENGOT-ov11: Binimetinib Versus Physician's Choice Chemotherapy in Recurrent or Persistent Low-Grade Serous Carcinomas of the Ovary, Fallopian Tube, or Primary Peritoneum
Bradley J Monk, Rachel N Grisham, Susana Banerjee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 23, 2025
Primary Analysis of EPIK-O/ENGOT-ov61: Alpelisib Plus Olaparib Versus Chemotherapy in Platinum-Resistant or Platinum-Refractory High-Grade Serous Ovarian Cancer Without <i>BRCA</i> Mutation
Panagiotis A Konstantinopoulos, Jae Weon Kim, Gilles Freyer, et al.
JCO Oncology Practice
|
May 30, 2020
InSight Care Pilot Program: Redefining Seeing a Patient
Bobby Daly, Gilad Kuperman, Alice Zervoudakis, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
June 24, 2025
Comprehensive Molecular, Pathological, and Clinical Characterization of Clear Cell Adenocarcinoma of the Urinary Tract
Rayan Rammal, Florestan J Koll, Ziyu Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 21, 2021
Secondary Cytoreduction and Carboplatin Hyperthermic Intraperitoneal Chemotherapy for Platinum-Sensitive Recurrent Ovarian Cancer: An MSK Team Ovary Phase II Study
Oliver Zivanovic, Dennis S Chi, Qin Zhou, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
February 5, 2021
Ovarian Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
Deborah K Armstrong, Ronald D Alvarez, Jamie N Bakkum-Gamez, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
October 16, 2024
NCCN Guidelines® Insights: Ovarian Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancer, Version 3.2024
Joyce Liu, Andrew Berchuck, Floor J Backes, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
September 8, 2022
NCCN Guidelines® Insights: Ovarian Cancer, Version 3.2022
Deborah K Armstrong, Ronald D Alvarez, Floor J Backes, et al.
JCO Precision Oncology
|
September 22, 2023
Germline Pathogenic Variants and Genetic Counseling by Ancestry in Patients With Epithelial Ovarian Cancer
Tiffany Y Sia, Anna Maio, Yelena M Kemel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 3, 2018
Clinical Utility of Prospective Molecular Characterization in Advanced Endometrial Cancer
Tara E Soumerai, Mark T A Donoghue, Chaitanya Bandlamudi, et al.
Page
of 84